amphetamine has been researched along with medroxyprogesterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andreatini, R; Baretta, IP; Gustafson, L; Ninomiya, EM; Rodrigues, AL; Sabioni, P | 1 |
1 review(s) available for amphetamine and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for amphetamine and medroxyprogesterone
| Article | Year |
|---|---|
The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Behavior, Animal; Benzophenanthridines; Contraceptives, Oral, Synthetic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hyperkinesis; Lithium Carbonate; Medroxyprogesterone; Mice; Protein Kinase C; Tamoxifen | 2008 |